Navigating Special Regulatory Pathways for Advanced Therapy Development Success
Explore how navigating special regulatory pathways can enhance drug development and help lead to improved patient access to innovative therapies.
Speakers:
- Herbert Altmann - VP Market Access & Healthcare Consulting at Cencora
- Christian Schneider - Vice President and Chief Medical Officer at Cencora Pharmalex
- Monica King - Senior Manager, Regulatory Affairs at Cook Myosite
- Nathalie Boeglin - Executive Director, Head of Regulatory Science, Early Stage Programs at Orchard Therapeutics
- Arvind Natarajan - Senior Vice President, Process & Analytical Development at Iovance Biotherapeutics
- Malou Gemeniano - Vice President, CMC Regulatory Affairs at Iovance Biotherapeutics
Fill out the form to watch the session
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.